Babak Givi

About

Dr. Babak Givi is a leading head and neck surgical oncologist whose pioneering work has centered on the adoption, safety, and refinement of transoral robotic surgery (TORS) for oropharyngeal cancers. His major contributions include comprehensive investigations into the patterns of metastasis and functional outcomes following TORS, particularly for accessing the challenging retropharyngeal lymph nodes. Dr. Givi’s landmark 2021 study on TORS adoption and safety, cited 38 times, provided critical evidence validating the procedure’s widespread use for oropharyngeal squamous cell carcinoma (OPSCC) following its FDA approval. His earlier work, including a 2015 case series (31 citations) and a 2017 study (24 citations), established a novel, minimally invasive robotic approach for retropharyngeal node dissection, demonstrating its feasibility and staging value. These contributions have directly shaped surgical guidelines and improved patient outcomes by reducing morbidity. Dr. Givi’s research bridges surgical innovation with rigorous safety data, making him a key figure in the evolution of robotic head and neck surgery.

Research Focus

Key Achievements

Top Papers

1. 1
   Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers

   38 citations · 2021
2. 2
   Transoral robotic retropharyngeal node dissection

   31 citations · 2015
3. 3
   Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes

   24 citations · 2017

Key Collaborators

Contact & Links